Protalix Company
Protalix is a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system. Its pipeline consists of proprietary, potentially clinically superior versions of recombinant therapeutic proteins that target established pharmaceutical markets.
Headquarters:
Carmiel, Israel
Employee Number:
200-500
Founded Date:
1993
Investment Stage:
N/A
Technology:
Biotechnology, Pharmaceutical, Therapeutics
Investor Type:
N/A
Number Of Exists:
N/A
Industry:
Personalized Medicine
Funding Status:
IPO